The health network will determine whether the results from YouScript's reports can inform decisions on pharmacogenetic testing of patients.
A Veterans Health Administration subcommittee evaluated the clinical utility of 30 pharmacogenetic tests and recommended about half for wider use.
MedTek21's software is designed to continuously analyze patient records to provide real-time personalized medication reports to physicians.
The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.
Recommendations for allele selection in CYP2C19 assays are the first of many planned pharmacogenetics assay recommendations from AMP.
Under the agreement, PGS.Holland will market Bio.logis' Genetic Information Management Suite in Benelux, Scandinavia, and the UK.
The $12 million PRIME study will involve 2,000 veterans with major depressive disorder and 250 healthcare providers across 21 VA medical centers.
For the three months ended Sept. 30, the firm reported total revenues of $190.2 million, compared to $177.5 million in Q1 2017, beating the consensus Wall Street estimate.
An international team of researchers examined the scope and population specificity of copy-number variants affecting genes linked to drug metabolism.
Genetic testing can help identify why people aren't responding to certain mental health medications, according to the Philadelphia Inquirer.
Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.
The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.
US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.
In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.